Sharon Manson's 45-year career in oncology nursing includes roles from bedside nurse to assistant vice president of oncology ...

Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a ...

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...

Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, ...

Disorganization, Smith said, is a common theme when it comes to the challenges around coordinating cancer care for a loved ...

A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on ...

A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, ...

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...